The Clorox Company (CLX)
USD 161.72
(-0.98%)
USD 161.72
(-0.98%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 695 Million | 1.15 Billion | 786 Million | 1.27 Billion | 1.54 Billion | 992 Million |
| Net Income | 280 Million | 161 Million | 471 Million | 719 Million | 939 Million | 820 Million |
| Depreciation & Amortization | 235 Million | 236 Million | 224 Million | 211 Million | 180 Million | 180 Million |
| Deferred income taxes | -100 Million | -149 Million | 5 Million | -32 Million | -2 Million | -20 Million |
| Stock-based compensation | 74 Million | 73 Million | 52 Million | 50 Million | 50 Million | 43 Million |
| Change in working capital | -241 Million | 354 Million | -99 Million | -11 Million | 349 Million | -2 Million |
| Other non-cash items | 1.11 Billion | 483 Million | 133 Million | 339 Million | 30 Million | -29 Million |
| Investing Cash Flow | -175 Million | -223 Million | -229 Million | -452 Million | -252 Million | -196 Million |
| Investments in PPE | -212 Million | -228 Million | -251 Million | -331 Million | -254 Million | -206 Million |
| Acquisitions | 17 Million | - | - | -85 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 20 Million | 5 Million | 22 Million | -36 Million | 2 Million | 10 Million |
| Financing Cash Flow | -655 Million | -753 Million | -689 Million | -1.39 Billion | -523 Million | -815 Million |
| Debt repayment | -45 Million | -188 Million | -1.4 Billion | -103 Million | -96 Million | -189 Million |
| Dividends payments | -595 Million | -583 Million | -571 Million | -558 Million | -533 Million | -490 Million |
| Common Stock Repurchased | - | - | -25 Million | -905 Million | -248 Million | -661 Million |
| Common Stock Issuance | 1 Million | 33 Million | 5 Million | 103 Million | 162 Million | 147 Million |
| Other Financing Activities | -16 Million | -170 Million | 1.3 Billion | 72 Million | 192 Million | 378 Million |
| Accounts receivables | -34 Million | -14 Million | -84 Million | 82 Million | -27 Million | -38 Million |
| Accounts payables | -140 Million | 157 Million | -47 Million | 311 Million | 291 Million | 17 Million |
| Inventory | 55 Million | 58 Million | -18 Million | -282 Million | 50 Million | -7 Million |
| Other working capital | -122 Million | 153 Million | 50 Million | -122 Million | 35 Million | 26 Million |
| Cash at beginning of period | 367 Million | 186 Million | 324 Million | 879 Million | 113 Million | 134 Million |
| Cash at end of period | 202 Million | 368 Million | 186 Million | 324 Million | 879 Million | 113 Million |
| Capital Expenditure | -212 Million | -228 Million | -251 Million | -331 Million | -254 Million | -206 Million |
| Effect of forex changes on cash | -26 Million | - | -6 Million | 12 Million | -5 Million | -2 Million |
| Net cash flow / Change in cash | -165 Million | 182 Million | -138 Million | -555 Million | 766 Million | -21 Million |
| Free Cash Flow | 483 Million | 930 Million | 535 Million | 945 Million | 1.29 Billion | 786 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 216 Million | 280 Million | -50 Million | 96 Million | 25 Million | 161 Million |
| Depreciation & Amortization | 59 Million | 235 Million | 58 Million | 57 Million | 61 Million | 236 Million |
| Deferred income taxes | 26 Million | -100 Million | -66 Million | -55 Million | -5 Million | -149 Million |
| Stock-based compensation | 19 Million | 74 Million | 26 Million | 16 Million | 13 Million | 73 Million |
| Change in working capital | 7 Million | -241 Million | -34 Million | -139 Million | -75 Million | 354 Million |
| Other non-cash items | 153 Million | 1.11 Billion | 10 Million | 178 Million | 1 Million | 483 Million |
| Investing Cash Flow | -81 Million | -175 Million | -38 Million | -33 Million | -23 Million | -223 Million |
| Investments in PPE | -81 Million | -212 Million | -55 Million | -52 Million | -24 Million | -228 Million |
| Acquisitions | - | 17 Million | 17 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -81 Million | 20 Million | 17 Million | 19 Million | 1 Million | 5 Million |
| Financing Cash Flow | -273 Million | -655 Million | -278 Million | -259 Million | 155 Million | -753 Million |
| Debt repayment | -106 Million | -45 Million | -134 Million | -103 Million | -298 Million | -188 Million |
| Dividends payments | -149 Million | -595 Million | -148 Million | -149 Million | -149 Million | -583 Million |
| Common Stock Repurchased | - | - | - | 110 Million | -298 Million | - |
| Common Stock Issuance | -2 Million | 1 Million | 4 Million | -7 Million | 6 Million | 33 Million |
| Other Financing Activities | -16 Million | -16 Million | -130 Million | -110 Million | 894 Million | -170 Million |
| Accounts receivables | -18 Million | -34 Million | -31 Million | -93 Million | 86 Million | -14 Million |
| Accounts payables | -20 Million | -140 Million | 43 Million | -25 Million | -138 Million | 157 Million |
| Inventory | 35 Million | 55 Million | -23 Million | 57 Million | -14 Million | 58 Million |
| Other working capital | 10 Million | -122 Million | -55 Million | -78 Million | -9 Million | 153 Million |
| Cash at beginning of period | 219 Million | 367 Million | 358 Million | 520 Million | 368 Million | 186 Million |
| Cash at end of period | 202 Million | 202 Million | 221 Million | 358 Million | 520 Million | 368 Million |
| Capital Expenditure | -81 Million | -212 Million | -55 Million | -52 Million | -24 Million | -228 Million |
| Effect of forex changes on cash | - | -26 Million | -3 Million | -23 Million | - | - |
| Net cash flow / Change in cash | -17 Million | -165 Million | -137 Million | -162 Million | 152 Million | 182 Million |
| Free Cash Flow | 259 Million | 483 Million | 127 Million | 101 Million | -4 Million | 930 Million |
ICABY
IMAGICAA
601019
LPK
603003
300870